July 2026

A comprehensive systematic review and meta-analysis published in the journal BIO Integration has found that routine vitamin D supplementation during pregnancy does not provide convincing evidence for preventing preterm birth. The analysis also highlighted that an apparent increase in preterm birth risk observed in one subgroup should be interpreted with caution because it was driven by a single clinical trial involving women living with HIV, rather than the broader pregnant population.

The Gujarat State Pharmacy Council (GSPC) has partnered with the Indian Pharmacopoeia Commission (IPC) to launch a dedicated "Pharmacovigilance & Medicine Safety" to strengthen medicine safety awareness and promote adverse drug reaction (ADR) reporting

Novo Nordisk has announced that the European Commission (EC) has approved Wegovy® (semaglutide) tablets for chronic weight management, making it the first oral GLP-1 receptor agonist authorized in the European Union for the treatment of obesity and overweight. The approval also includes a single, ready-to-use 7.2 mg Wegovy injection pen, providing healthcare professionals and patients with additional treatment options.

Sanofi has filed a patent infringement lawsuit against Moderna in the U.S. District Court for the District of New Jersey, alleging that Moderna's mRNA vaccine technologies infringe a portfolio of patents originally developed by Translate Bio, a biotechnology company acquired by Sanofi in 2021. The complaint names Translate Bio, Translate Bio MA, Sanofi Vaccines US, and VaxServe as plaintiffs, while Moderna, ModernaTX, and Moderna US are listed as defendants.